InvestorsHub Logo
Followers 30
Posts 2228
Boards Moderated 0
Alias Born 12/13/2016

Re: tredenwater2 post# 158588

Friday, 07/20/2018 5:08:02 PM

Friday, July 20, 2018 5:08:02 PM

Post# of 471396
Tred.....exciting analogy and I know the Delta having been stationed at Travis AFB in the 80's flying C-5's (a similar "Air Freighter"). There is an advantage gained from being small and nimble if you play the "wake" right. Chris and the Anavex bunch have leveraged well by getting as many other entities to carry our water (see previous post below). The freighter's (Biogen) captain is blowing his horn but we are long gone and will be in port well before him. By the way, I'm not sure who LSL 1953 is but, I've read all the mysteries Joe and Frank got into.

---------

"Mapman and many others have supplied a number of peer reviewed abstracts on Sigma-1 research while the pre-clinical/clinical research on 2-73 for Alzheimer's, Parkinson's, Fragile X, Angelman's and Epilepsy has been conducted by very credible academic, medical and governmental entities like the University of Montpellier, Dresden University, The German Health Authority, Rosekamp Institute, Australian Health Authority, FDA, Melbourne/Alfred Health, University of South Florida, National Academy of Science, NIH, MJFF, FRAXA Research Foundation, Foundation for Angelman Syndrome, Baylor College of Medicine, Rett Syndrome Foundation, Lund University, MaGill University, and Wayne State University.

Three National Health Authorities, three Health Agencies, seven Universities, and four foundations along with presentations at a number of prestigious medical conferences says a lot about the vetting of the Sigma-1 concept and our drug.........that Anavex is carefully and thoroughly developing 2-73's wide application in a significant number of neurodegenerative diseases is very hard to dispute."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News